New Data on Investigational Agent Belatacept in Kidney Transplant Recipients ... - Business Wire (press release) PDF Print
Business Wire (press release)
“The breadth of Bristol-Myers Squibb's clinical data on belatacept at the American Transplant Congress demonstrates our ongoing commitment to address the unmet medical needs of patients in the renal transplant community.” Three-Year Outcomes from

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.